Guenther Koehne

Title: Guenther Koehne: Innovator in Cellular Therapy

Introduction

Guenther Koehne is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of cellular therapy. With a total of 3 patents, he has made strides in developing methods that enhance therapeutic options for patients suffering from various diseases, including cancer.

Latest Patents

Koehne's latest patents include innovative methods for selecting T cell lines and donors for adoptive cellular therapy. These methods focus on identifying an allogeneic T cell line suitable for therapeutic administration to patients with pathogens or cancer. Additionally, he has developed methods for treating CMV (cytomegalovirus) retinitis through T cell therapy. This treatment involves administering a population of allogeneic T cells that are specific to CMV, particularly for patients infected with HIV or those who have received solid organ transplants.

Career Highlights

Throughout his career, Guenther Koehne has worked with esteemed institutions such as Memorial Sloan Kettering Cancer Center and Cornell University. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cellular therapies.

Collaborations

Koehne has had the opportunity to work alongside notable colleagues, including Richard John O'Reilly and Ekaterina Doubrovina. These collaborations have further enriched his research and development efforts in the realm of T cell therapies.

Conclusion

Guenther Koehne's innovative work in cellular therapy exemplifies the impact of dedicated inventors in advancing medical treatments. His patents and collaborations continue to pave the way for new therapeutic strategies that can significantly improve patient outcomes.